Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H25F3N4O3S |
| Molecular Weight | 506.541 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=CC(NC2=NC=CC(=N2)C(F)(F)F)=C1)C3=CN=C(S3)[C@@]4(O)CC[C@H](C(O)=O)C(C)(C)C4
InChI
InChIKey=LDDBKIFZPGDEND-WAIKUNEKSA-N
InChI=1S/C24H25F3N4O3S/c1-13-8-14(10-15(9-13)30-21-28-7-5-18(31-21)24(25,26)27)17-11-29-20(35-17)23(34)6-4-16(19(32)33)22(2,3)12-23/h5,7-11,16,34H,4,6,12H2,1-3H3,(H,32,33)(H,28,30,31)/t16-,23-/m1/s1
| Molecular Formula | C24H25F3N4O3S |
| Molecular Weight | 506.541 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:51:30 GMT 2023
by
admin
on
Sat Dec 16 02:51:30 GMT 2023
|
| Record UNII |
OOA78Q9G2I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OOA78Q9G2I
Created by
admin on Sat Dec 16 02:51:30 GMT 2023 , Edited by admin on Sat Dec 16 02:51:30 GMT 2023
|
PRIMARY | |||
|
1312518-84-5
Created by
admin on Sat Dec 16 02:51:30 GMT 2023 , Edited by admin on Sat Dec 16 02:51:30 GMT 2023
|
PRIMARY | |||
|
53251506
Created by
admin on Sat Dec 16 02:51:30 GMT 2023 , Edited by admin on Sat Dec 16 02:51:30 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
Dropped from clinical trials because of adverse events probably bleeding.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
